nad has been researched along with Hepatitis B in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbati, G; Acerbi, G; Alfieri, A; Barili, V; Boarini, C; Boni, C; Borghi, M; Ceccatelli Berti, C; Degasperi, E; Ferrari, C; Fisicaro, P; Laccabue, D; Lampertico, P; Loglio, A; Massari, M; Missale, G; Montali, I; Montanini, B; Morselli, M; Pedrazzi, G; Penna, A; Perbellini, R; Pesci, M; Reverberi, V; Rossi, M; Tiezzi, C; Vecchi, A | 1 |
| Harimoto, N; Ikegami, T; Konishi, H; Maehara, Y; Nakagawara, H; Oda, Y; Shirabe, K; Soejima, Y; Yamashita, Y; Yoshizumi, T | 1 |
2 other study(ies) available for nad and Hepatitis B
| Article | Year |
|---|---|
Deregulated intracellular pathways define novel molecular targets for HBV-specific CD8 T cell reconstitution in chronic hepatitis B.
Topics: Antiviral Agents; CD8-Positive T-Lymphocytes; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; NAD; Reactive Oxygen Species | 2023 |
Suppression of silent information regulator 1 activity in noncancerous tissues of hepatocellular carcinoma: Possible association with non-B non-C hepatitis pathogenesis.
Topics: Acetylation; Animals; Carcinoma, Hepatocellular; Case-Control Studies; Cell Hypoxia; Fatty Liver, Alcoholic; Female; Gene Expression Regulation; Hep G2 Cells; Hepatitis; Hepatitis B; Hepatitis C; Histones; Humans; Liver Neoplasms; Mice, Inbred C57BL; NAD; Non-alcoholic Fatty Liver Disease; Pregnancy; Retrospective Studies; Sirtuin 1 | 2015 |